{"id":16050,"date":"2016-07-06T15:20:35","date_gmt":"2016-07-06T13:20:35","guid":{"rendered":"http:\/\/mabdesign.fr\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/"},"modified":"2016-07-06T15:20:35","modified_gmt":"2016-07-06T13:20:35","slug":"genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/","title":{"rendered":"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS"},"content":{"rendered":"

Genticel, soci\u00e9t\u00e9 fran\u00e7aise de biotechnologie, qui d\u00e9veloppe des immunoth\u00e9rapies innovantes pour pr\u00e9venir les cancers induits par le virus du papillome humain (HPV), annonce aujourd’hui avoir engag\u00e9 la soci\u00e9t\u00e9 Eumedix, sp\u00e9cialiste europ\u00e9en reconnu de la finance d’entreprise, en tant que conseiller strat\u00e9gique.<\/p>\n

Lire le communiqu\u00e9 de presse<\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Genticel, soci\u00e9t\u00e9 fran\u00e7aise de biotechnologie, qui d\u00e9veloppe des immunoth\u00e9rapies innovantes pour pr\u00e9venir les cancers induits par le virus du papillome humain (HPV), annonce aujourd’hui avoir engag\u00e9 la soci\u00e9t\u00e9 Eumedix, sp\u00e9cialiste europ\u00e9en reconnu de la finance d’entreprise, en tant que conseiller strat\u00e9gique.<\/p>\n","protected":false},"author":1,"featured_media":585,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,13],"tags":[],"class_list":["post-16050","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites","category-nos-adherents"],"yoast_head":"\nGENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS - MabDesign<\/title>\n<meta name=\"description\" content=\"Genticel, soci\u00e9t\u00e9 fran\u00e7aise de biotechnologie, qui d\u00e9veloppe des immunoth\u00e9rapies innovantes pour pr\u00e9venir les cancers induits par le virus du papillome humain (HPV), annonce aujourd'hui avoir engag\u00e9 la soci\u00e9t\u00e9 Eumedix, sp\u00e9cialiste europ\u00e9en reconnu de la finance d'entreprise, en tant que conseiller strat\u00e9gique.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Genticel, soci\u00e9t\u00e9 fran\u00e7aise de biotechnologie, qui d\u00e9veloppe des immunoth\u00e9rapies innovantes pour pr\u00e9venir les cancers induits par le virus du papillome humain (HPV), annonce aujourd'hui avoir engag\u00e9 la soci\u00e9t\u00e9 Eumedix, sp\u00e9cialiste europ\u00e9en reconnu de la finance d'entreprise, en tant que conseiller strat\u00e9gique.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2016-07-06T13:20:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"885\" \/>\n\t<meta property=\"og:image:height\" content=\"193\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS\",\"datePublished\":\"2016-07-06T13:20:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/\"},\"wordCount\":74,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Nos adh\u00e9rents\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/\",\"name\":\"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg\",\"datePublished\":\"2016-07-06T13:20:35+00:00\",\"description\":\"Genticel, soci\u00e9t\u00e9 fran\u00e7aise de biotechnologie, qui d\u00e9veloppe des immunoth\u00e9rapies innovantes pour pr\u00e9venir les cancers induits par le virus du papillome humain (HPV), annonce aujourd'hui avoir engag\u00e9 la soci\u00e9t\u00e9 Eumedix, sp\u00e9cialiste europ\u00e9en reconnu de la finance d'entreprise, en tant que conseiller strat\u00e9gique.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg\",\"width\":885,\"height\":193,\"caption\":\"GENTICEL\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS - MabDesign","description":"Genticel, soci\u00e9t\u00e9 fran\u00e7aise de biotechnologie, qui d\u00e9veloppe des immunoth\u00e9rapies innovantes pour pr\u00e9venir les cancers induits par le virus du papillome humain (HPV), annonce aujourd'hui avoir engag\u00e9 la soci\u00e9t\u00e9 Eumedix, sp\u00e9cialiste europ\u00e9en reconnu de la finance d'entreprise, en tant que conseiller strat\u00e9gique.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/","og_locale":"en_US","og_type":"article","og_title":"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS - MabDesign","og_description":"Genticel, soci\u00e9t\u00e9 fran\u00e7aise de biotechnologie, qui d\u00e9veloppe des immunoth\u00e9rapies innovantes pour pr\u00e9venir les cancers induits par le virus du papillome humain (HPV), annonce aujourd'hui avoir engag\u00e9 la soci\u00e9t\u00e9 Eumedix, sp\u00e9cialiste europ\u00e9en reconnu de la finance d'entreprise, en tant que conseiller strat\u00e9gique.","og_url":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/","og_site_name":"MabDesign","article_published_time":"2016-07-06T13:20:35+00:00","og_image":[{"width":885,"height":193,"url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg","type":"image\/jpeg"}],"author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS","datePublished":"2016-07-06T13:20:35+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/"},"wordCount":74,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg","articleSection":["Actualit\u00e9s","Nos adh\u00e9rents"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/","url":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/","name":"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg","datePublished":"2016-07-06T13:20:35+00:00","description":"Genticel, soci\u00e9t\u00e9 fran\u00e7aise de biotechnologie, qui d\u00e9veloppe des immunoth\u00e9rapies innovantes pour pr\u00e9venir les cancers induits par le virus du papillome humain (HPV), annonce aujourd'hui avoir engag\u00e9 la soci\u00e9t\u00e9 Eumedix, sp\u00e9cialiste europ\u00e9en reconnu de la finance d'entreprise, en tant que conseiller strat\u00e9gique.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo_Genticel_Word_noslogan.jpg","width":885,"height":193,"caption":"GENTICEL"},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/genticel-designe-eumedix-comme-conseiller-strategique-dans-sa-recherche-de-nouveaux-medicaments-candidats-innovants\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"GENTICEL D\u00c9SIGNE EUMEDIX COMME CONSEILLER STRAT\u00c9GIQUE DANS SA RECHERCHE DE NOUVEAUX M\u00c9DICAMENTS-CANDIDATS INNOVANTS"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=16050"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16050\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/585"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=16050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=16050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=16050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}